Wall Street Analysts Predict a 25.59% Upside in BioNTech (BNTX): Here's What You Should Know

BioNTech SE Sponsored ADR (BNTX) closed the last trading session at $112.76, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $141.61 indicates a 25.6% upside potential.The mean estimate comprises 17 short-term price targets with a standard deviation of $17.52. While the lowest estimate of $121 indicates a 7.3% increase from the current price level, the most optimistic ...